Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) are highly reactive molecules derived from oxygen that can cause cellular damage by oxidizing DNA, lipids, and proteins. ROS are involved in various physiological processes, including signaling and immune responses, but excessive levels can lead to oxidative stress, contributing to diseases like cancer, cardiovascular disease, and neurodegenerative disorders. Antioxidants are used to mitigate ROS-mediated damage by reducing oxidative stress.
Antioxidants work by neutralizing ROS, thereby reducing oxidative stress and cellular damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive Oxygen Species (ROS)-mediated Cellular Damage (ROS).